MedTrace Logo

Neuroscience of Marijuana Impaired Driving

NCT02757313 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2024-07-23

No results posted yet for this study

Summary

Marijuana is one of the most widely used substances. However, marijuana intoxication is not fully understood in relation to driving. This study will help the investigators learn more about the potential impairments related to marijuana intoxicated driving. A combination of MRI and neuropsychological tests (which are computer and paper/pencil tasks) will be used to measure intoxication and impairment. This study will also assess levels of marijuana in blood and saliva samples. This study takes place in Hartford, Connecticut.

Conditions

  • Marijuana Impairment

Interventions

DRUG

Low dose THC marijuana

DRUG

High dose THC marijuana

DRUG

Placebo marijuana

Sponsors & Collaborators

  • Hartford Hospital

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Montana State University

    collaborator OTHER

  • Maastricht University

    collaborator OTHER

  • The Mind Research Network

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Godfrey Pearlson · Founding Director Olin Research Center; Professor Yale University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02757313 on ClinicalTrials.gov